Status:
COMPLETED
Macular Appearance After Diabetic Vitrectomy
Lead Sponsor:
National Taiwan University Hospital
Conditions:
Proliferative Diabetic Retinopathy
Vitrectomy
Eligibility:
All Genders
20-85 years
Brief Summary
Vitrectomy is one of the major treatment methods for complications of diabetic retinopathy. As surgical techniques and instruments improve, high anatomical success may be achieved; however, functional...
Detailed Description
From June 2008 to December 2008 consecutive patients undergo pars plana vitrectomy for diabetic fibrovascular proliferation were included in the study. All cases have fibrovascular proliferation with...
Eligibility Criteria
Inclusion
- From June 2008 to December 2008 consecutive patients undergo pars plana vitrectomy for diabetic fibrovascular proliferation are included in our study.
- All cases have fibrovascular proliferation with vitreo-retinal adhesions in 3 or more sites but not extending beyond equator in more than one quadrant.
- Complete removal of the visible posterior preretinal membrane must be done during surgery in every case.
- All cases are included in the study have attached retina postoperatively.
Exclusion
- Cases with rhegmatogenous detachment, silicone oil infusion, or post-operative moderate to dense cataract are excluded.
- Patients are unable to follow-up regularly are not included.
- Patient refuses to join our study.
Key Trial Info
Start Date :
May 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2006
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT00737022
Start Date
May 1 2005
End Date
December 1 2006
Last Update
August 18 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Ophthalmology, National Taiwan University Hospital
Taipei, Taiwan, 100